Clearside Biomedical Completes $16 Million Series B Financing

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ALPHARETTA, Ga.--(BUSINESS WIRE)--Clearside Biomedical, Inc., today announced the closing of a $16 million Series B financing. The financing included new investor RusnanoMedInvest (RMI) and existing investors Hatteras Venture Partners, Santen Pharmaceuticals Co. Ltd., Mountain Group Capital and Georgia Research Alliance Venture Fund.

Help employers find you! Check out all the jobs and post your resume.

Back to news